12. WARRANTS

The following table presents information about warrants to purchase common stock issued and outstanding at March 31, 2020:


		Number of	Exercise
Year Issued	Classification	Warrants	Price		Date of Expiration
2014	Equity	11	$	352.50	5/9/2021
2016	Equity	2,865	$	7,500.00	3/18/2021
2018	Equity	211,921	$	6.98	6/25/2023
2019	Equity	15,168	$	4.50	11/21/2024
2020	Equity	2,545,455	$	2.75	3/10/2025
2020	Equity	165,455	$	3.4375	3/5/2025
2020	Equity	573,305	$	0.00001	Until Fully Exercised
Total		3,514,180
Weighted average exercise price			$	8.71
Weighted average life in years					4.82

In March 2020 and March 2016, the Company issued warrants as part of public offerings. The Company assessed whether the warrants issued in both the March 2016 and March 2020 Offering required accounting as derivatives and determined that the warrants were (1) indexed to the Company’s own stock and (2) classified in stockholders’ equity in accordance with Accounting Standards Codification (“ASC”) Topic 815, Derivatives and Hedging. As such, the Company concluded that the warrants meet the scope exception for determining whether the instruments require accounting as derivatives and accordingly are classified in stockholders’ equity.

In November 2019, the Company agreed to issue the Placement Agent Warrants and in January 2020 the Company issued the Placement Agent Warrants. The Placement Agent Warrants were considered issued for accounting purposes as of November 2019 pursuant to the guidance in ASC Topic 815, Derivatives and Hedging. The Company assessed whether the warrants required accounting as derivatives and determined that the warrants were (1) indexed to the Company’s own stock and (2) classified in stockholders’ equity in accordance with ASC Topic 815, Derivatives and Hedging. As such, the Company concluded that the warrants meet the scope exception for determining whether the instruments require accounting as derivatives and accordingly are classified in stockholders’ equity.

In May 2014 and June 2018, the Company issued warrants in a public offering. At inception, the 2014 and 2018 Warrants had provisions that precluded equity classification. Upon amendment of the 2014 and 2018 warrants in May 2018 and September 2018, respectively, the Company assessed whether the warrants required accounting as derivatives and determined that the warrants were (1) indexed to the Company’s own stock and (2) classified in stockholders’ equity in accordance with ASC Topic 815, Derivatives and Hedging. As such, the Company concluded that the warrants meet the scope exception for determining whether the instruments required accounting as derivatives and accordingly are classified in stockholders’ equity.